Purchases and Sales Made in Q4 2021 in Innate Pharma Sa (IPHA)
This table provides information about the institutional ownership of Innate Pharma Sa (IPHA) during Q4 2021. The information is specifically focused on institutions that hold shares of Innate Pharma SA.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 10, 2022
Q4 2021
|
Black Rock Inc.
New York, NY |
BUY
|
- |
396KNew |
$1.72M - $2.4M
|
396K
$701K
|
|
|
Feb 14, 2022
Q4 2021
|
Silverarc Capital Management, LLC
|
BUY
|
- |
184KNew |
$799K - $1.12M
|
184K
$326K
|
|
|
Feb 09, 2022
Q4 2021
|
Alps Advisors Inc
Denver, CO |
BUY
|
- |
93.7KNew |
$407K - $568K
|
93.7K
$166K
|
|
|
Feb 14, 2022
Q4 2021
|
Optiver Holding B.V.
Amsterdam, P7 |
BUY
|
- |
78.2K+ 71.73% |
$339K - $474K
|
187K
$331K
|
|
|
Feb 08, 2022
Q4 2021
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
73K+ 41.9% |
$317K - $442K
|
247K
$437K
|
|
|
Feb 14, 2022
Q4 2021
|
Two Sigma Investments, LP
New York, NY |
BUY
|
- |
48.2K+ 256.13% |
$209K - $292K
|
67.1K
$119K
|
|
|
Feb 14, 2022
Q4 2021
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
- |
27.9K+ 102.89% |
$121K - $169K
|
55K
$97.4K
|
|
|
Feb 14, 2022
Q4 2021
|
Morgan Stanley
New York, NY |
BUY
|
- |
21.6K+ 121.84% |
$93.7K - $131K
|
39.3K
$69.6K
|
|
|
Feb 14, 2022
Q4 2021
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
BUY
|
- |
12.3KNew |
$53.4K - $74.5K
|
12.3K
$21.8K
|
|
|
Feb 10, 2022
Q4 2021
|
Citigroup Inc
|
BUY
|
- |
44New |
$191 - $267
|
44
$77.9
|
|
|
Feb 07, 2022
Q4 2021
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Point72 Hong Kong LTD
Hong Kong, K3 |
SELL
|
- |
-943Closed |
$4.09K - $5.71K
|
0
$0
|
|
|
Feb 15, 2022
Q4 2021
|
Vectors Research Management, LLC
New York, NY |
SELL
|
- |
-1KClosed |
$4.34K - $6.06K
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Pura Vida Investments, LLC
New York, NY |
SELL
|
- |
-2.61K- 3.17% |
$11.3K - $15.8K
|
79.9K
$141K
|
|
|
Feb 14, 2022
Q4 2021
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-6.8K- 94.31% |
$29.5K - $41.2K
|
410
$726
|
|
|
Feb 15, 2022
Q4 2021
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-9.71K- 39.73% |
$42.1K - $58.8K
|
14.7K
$26.1K
|
|
|
Feb 14, 2022
Q4 2021
|
Two Sigma Securities, LLC
New York, NY |
SELL
|
- |
-17.1KClosed |
$74.3K - $104K
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Lpl Financial LLC
Fort Mill, SC |
SELL
|
- |
-18.4KClosed |
$79.9K - $112K
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Cubist Systematic Strategies, LLC
Stamford, CT |
SELL
|
- |
-20.1KClosed |
$87.4K - $122K
|
0
$0
|
|
|
Feb 17, 2022
Q4 2021
|
Virtu Financial LLC
New York, NY |
SELL
|
- |
-97.8K- 89.29% |
$425K - $593K
|
11.7K
$20.8K
|
|
|
Feb 11, 2022
Q4 2021
|
Affinity Asset Advisors, LLC
New York, NY |
SELL
|
- |
-125KClosed |
$543K - $758K
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Balyasny Asset Management LLC
Chicago, IL |
SELL
|
- |
-187KClosed |
$814K - $1.14M
|
0
$0
|